NCT05141825已完成不适用
Proton and Carbon Ion Radiotherapy for Cervical Cancer : A Retrospective Analysis
Shanghai Proton and Heavy Ion Center0 个研究点目标入组 16 人开始时间: 2016年1月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 16
- 主要终点
- Number of participants with treatment-related adverse events as assessed by CTCAE v4.0
研究概览
简要总结
The aim of this study is to evaluate the toxicity and tolerance of proton and carbon ion radiotherapy (PCRT) for cervical cancer.
详细描述
To retrospectively analyze cervical cancer patients received radical proton and carbon radiotherapy in our center. The acute and late toxicities, overall survival (OS), local control rate (LC), progression-free survival (PFS) and distant metastasis-free survival (DMFS) were analyzed.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •. histologically diagnosis of squamous cell carcinoma of the cervix;
- •. International Federation of Gynecology and Obstetrics (FIGO) stage (2014) IB2 - IIIB, without rectum invasion; or FIGO stage IA - IB1, who refused surgery or were contraindication for surgery due to comorbidity diseases;
- •. received proton and carbon ion radiotherapy (PCRT) with or without chemotherapy for curative intention;
- •. Follow-up data available.
排除标准
- •a previous history of other malignancy;
- •squamous cell carcinoma of the cervix patients who had received surgery;
- •rectum was invaded.
结局指标
主要结局
Number of participants with treatment-related adverse events as assessed by CTCAE v4.0
时间窗: through study completion, an average of 1 year
Number of participants with treatment-related adverse events as assessed by CTCAE v4.0
次要结局
- overall survival rate(3 years)
- local control rate(3 years)
- progression-free survival(3 years)
- distant metastasis-free survival(3 years)
研究者
Zhan Yu
physician of abdorminal and pelvic oncology department
Shanghai Proton and Heavy Ion Center
相似试验
已完成
不适用
Proton and Carbon Ion Radiotherapy for Locally Advanced Pancreatic CancerPancreatic CarcinomaNCT03949933Shanghai Proton and Heavy Ion Center10
进行中（未招募）
不适用
Carbon Ion Radiotherapy for Locally Advanced Pancreatic CancerPancreatic CarcinomaNCT04082455Shanghai Proton and Heavy Ion Center49
招募中
不适用
Carbon Ion Radiotherapy for Recurrent Pancreatic Cancer Post SurgeryPancreatic CarcinomaNCT05830019Shanghai Proton and Heavy Ion Center49
终止
不适用
Carbon Ion Radiotherapy for the Treatment of Chinese Hepatocellular CarcinomaHepatocellular CarcinomaNCT02802124Shanghai Proton and Heavy Ion Center30
Unknown
2 期
Carbon Ion Radiotherapy in Treating Patients Undergoing Systemic Therapy for Oligo-metastatic Prostate CancerMetastatic Prostate CarcinomaNCT02935023Shanghai Proton and Heavy Ion Center47